Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 76, Issue 3, 2010, Pages 475-485

  Setthacheewakul, Saipin ^a   Mahattanadul, Sirima ^a   Phadoongsombut, Narubodee ^a   Pichayakorn, Wiwat ^a   Wiwattanapatapee, Ruedeekorn ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Curcumin; Oral absorption; Pellets; Self microemulsifying drug delivery systems; SMEDDS

Indexed keywords

CREMOPHOR; CURCUMIN; LABRASOL; SURFACTANT;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; MALE; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PELLET EXTRUSION; RAT; SUSPENSION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL AVAILABILITY; CURCUMIN; DRUG DELIVERY SYSTEMS; DRUG IMPLANTS; DRUG STABILITY; EMULSIFYING AGENTS; EMULSIONS; MALE; OILS; PARTICLE SIZE; RATS; RATS, WISTAR; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 78049295075     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.07.011     Document Type: Article

References (36)

1. Ruby A.J., Kuttan G., Babu K.D., Rajasekharan K.N., Kuttan R. Anti-tumor and antioxidant activity of natural curcuminoids. Cancer Lett. 1995, 94:79-83.
2. Lukita A.W., Ito Y., Baker G.L., McCuskey R.S. Effect of curcuminoids as anti-inflammatory agents on the hepatic microvascular response to endotoxin. Shock 2002, 17:399-403.
3. Johnson J.J., Mukhtar H. Curcumin for chemopreventive of colon cancer. Cancer Lett. 2007, 255:170-181.
4. Patil T.N., Srinivasan M. Hypocholesteremic effect of curcumin in induced-hypercholesteremic rats. Indian J. Exp. Biol. 1971, 9:167-169.
5. Ramaprasad C., Sirsi M. Indian medical plants: Curcuma longa; in vitro antibacterial activity of curcumin and the essential oil. J. Sci. Ind. Res. 1956, 15C:239-241.
6. Ammon H.P.T., Wahl M.A. Pharmacology of Curcuma longa. Planta Med. 1991, 57:1-7.
7. Park E.J., Jeon C.H., Ko G., Kim J., Sohn D.H. Protective effect of curcumin in rat liver injury induced by carbon tetrachloride. J. Pharm. Pharmacol. 2000, 52:437-440.
8. Dhillon N., Wolff R.A., Abbruzzese J.L., Hong D.S., Camachi L.H., Li L. Phase II clinical trial of curcumin in patients with advanced pancreatic cancer. J. Clin. Oncol. 2006, 24:14151.
9. Holt P.R., Katz S., Kirshoff R. Curcumin therapy in inflammatory bowel disease: a pilot study. Dig. Dis. Sci. 2005, 50:2191-2193.
10. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 1997, 15:1867-1876.
11. Ansari M.J., Ahmad S., Kohli K., Ali J., Khar R.K. Stability-indicating HPTLC determination of curcumin in bulk drug and pharmaceutical formulations. J. Pharm. Biomed. Anal. 2005, 39:132-138.
12. Shankar T., Shantha N., Ramesh H., Murthy I., Murthy V. Toxicity studies on turmeric (Curcuma longa): acute toxicity studies in rats, guinea pigs and monkeys. Indian J. Exp. Biol. 1980, 18:73-75.
13. Lao C., Ruffin M., Normolle D., Health D., Murray S., Bailey J. Dose escalation of curcuminoid formulation. BMC Complement Altern. Med. 2006, 6:10-15.
14. Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S.S.R. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998, 64:353-356.
15. Xu D.H., Wang S., Jin J., Mei X.T., Xu S.B. Dissolution and absorption researches of curcumin in solid dispersions with the polymers PVP. Asian J. Phamacodyn. Pharmacokinet. 2006, 6:343-349.
16. Maiti K., Mukherjee K., Gantait A., Saha B.P., Mukherjee P.K. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int. J. Pharm. 2007, 330:155-163.
17. Shaikh J., Ankola D.D., Beniwal V., Singh D., Ravi Kumar M.N.V. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 2009, 37:223-230.
18. Takahashi M., Uechi S., Takara K., Asikin Y., Wada K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J. Agric. Food Chem. 2009, 57:9141-9146.
19. Constantinides P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 1995, 12:1561-1572.
20. Constantinides P.P., Scalart J. Formulation and physical characterization of water-in-oil microemulsion containing long-versus medium-chain glycerides. Int. J. Pharm. 1997, 158:57-68.
21. Charman S.A., Charman W.N., Rogge M.C., Wilson T.D., Dutko F.J., Pouton C.W. Self-emulsifying drug delivery systems: formulation and biopharmaceutical evaluation of an investigational lipophillic compound. Pharm. Res. 1992, 9:87-93.
22. Shah N.H., Carvajai M.T., Patel C.I., Infeld M.H., Malick A.W. Self-emulsifying drug delivery systems (SMEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int. J. Pharm. 1994, 106:15-23.
23. Kang B.K., Lee J.S., Chon S.K., Jeong S.Y., Yuk S.H., Khang G., Lee H.B., Cho S.H. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm. 2004, 274:65-73.
24. Zhang P., Liu Y., Feng N., Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 2008, 355:269-276.
25. Khoo S.M., Humberstone A.J., Porter C.J.H., Edwards G.A., Charman W.N. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int. J. Pharm. 1998, 167:155-164.
26. Wang Z., Sun J., Wang Y., Liu X., Liu Y., Fu Q., Meng P., He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 2010, 383:1-6.
27. Yi T., Wan J., Xu H., Yang X. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur. J. Pharm. Sci. 2008, 34:274-280.
28. Ramshankar Y.V., Suresh S., Devi K. Novel self-emulsifying formulation of curcumin with improved dissolution, antiangiogenic and anti-inflammatory activity. Clin. Res. Regul. Aff. 2008, 25:213-234.
29. Cui J., Yu B., Zhao Y., Zhu W., Li H., Lou H., Zhai G. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 2009, 371:148-155.
30. Podczeck F. A novel aid for the preparation of pellets by extrusion/spheronization. Pharm. Tech. Eur. 2008, 20:26-31.
31. Olliaro P.L., Nair N.K., Sathasivam K., Mansor S.M., Naverratnam V. Pharmacokinetics of artesunate after single oral administration to rats. BMC Pharmacol. 2001, 1-4.
32. Narang A.S., Delmarre D., Gaoc D. Stable drug encapsulation in micelles and microemulsions. Int. J. Pharm. 2007, 345:9-25.
33. Spernath A., Aserin A., Garti N. Fully dilutable microemulsions embedded with phospholipids and stabilized by short-chain organic acids and polyols. J. Colloid Interface Sci. 2006, 299:900-909.
34. N'Diaye A., Jannin V., Berard V., Andres C., Pourcelot Y. Comparative study of the lubricant performance of Compritol® HD5 ATO and Compritol® 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. Int. J. Pharm. 2003, 254:263-269.
35. Gursoy R.N., Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 2004, 58:173-182.
36. Lindmark T., Nikkila T., Artursson P. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 monolayers. J. Pharmacol. Exp. Ther. 1995, 275:958-964.